REPROCELL Bioserve™
Diagnostic Services
Under the guidance of a quality control (QC) manager and supervising physician, our clinical laboratory technicians have worked with over 300 medical institutions throughout Japan and many hundreds more in the USA, India, and Europe. Our screening tests offer superior accuracy and efficacy compared to standard methods of diagnosis.
Our Diagnostic Services
PreciONC Oncology
Bioserve India
Our pharmacogenomics assays can help clinicians to make better decisions about treatment choices and prescribing. These integrated molecular diagnostic solutions can assist at every stage of the cancer journey:
- Hereditary risk assessment
- Diagnosis and Prognosis
- Treatment selection and monitoring
- Disease surveillance
HLA Typing and Crossmatching
As experts in human tissue research, we offer a comprehensive range of diagnostic tests that can screen for the presence of donor-specific antibodies (DSA) before or after transplantation. We use up to four different diagnostic tests in our HLA typing service:
- Flowcytometric crossmatching (FCXM)
- Anti-HLA antibody screening and single antigen identification (Class I & II)
- HLA typing
COVID PCR Testing
In 2021 we launched a high throughput Covid-19 identification service to contribute to the end of the pandemic. This PCR-based method uses SmartAmp and Allplex screening to identify coronavirus variants. The Allplex system can simultaneously detect:
- HV69/70 del mutation found in the UK variant
- E484K found in the South African and Brazilian variants
- N501Y found in all three novel variants
